Beijing Kailai Tiancheng Pharmaceutical Technology

Beijing Kailai Tiancheng Pharmaceutical Technology is a China-based biotechnology company focused on the research and development of innovative small molecule drugs, particularly in the field of metabolic diseases. The company specializes in developing treatments for type 2 diabetes and obesity, with a pipeline that includes GLP-1 receptor agonists and other metabolic regulators. In addition to its internal drug discovery programs, Kailai Tiancheng provides pharmaceutical technology services and contract research to the broader life sciences industry. The firm leverages its expertise in medicinal chemistry and clinical development to advance candidates from early-stage discovery through clinical trials.